Revolade® ITP Patient Brochure (French)
Brochure patient Thrombocytopénie immunologique primaire
Download French document
Indication - Kisqali
KISQALI is indicated for the treatment of women with hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as...
Twitter Linkedin Facebook Pinterest Google plusPatient Resources - Kisqali
Efficacy - Kisqali
The efficacy of Kisqali has been investigated in various studies. The following pictures summarize all the main data’s from the MONALEESA 2, 3, 7 studiesTwitter Linkedin Facebook Pinterest Google plusUseful tools & Links - Oncology
Scemblix® Patient Brochure (French)
Information brochure for patients Download French documentScemblix® Patient Brochure (Dutch)
Information brochure for patients Download Dutch documentReimbursement / eHealth - Lucentis
Indications
Patient Resources
×